Analyst Ratings for Maze Therapeutics (MAZE)
MAZE Rating Summary
MAZE Price Target Summary
- Highest: $110.00 (H.C. Wainwright)
- Lowest: $46.00 (Guggenheim)
- Average: $64.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$64.00 (+141.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/22/2026 | TD Cowen | Phil | New Coverage | Buy (N/A) |
N/A (N/A) |
28.93 (26.53) |
-8.3% | Details |
| 3/17/2026 | Truist Securities » Updated 4/13/2026 |
Danielle Brill | New Coverage | Buy (N/A) |
64.00 (68.00) |
51.26 (26.53) |
-48.24% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
